Cost-effectiveness and Laboratory Turnaround Time using Expanded Point-of-Care Testing in the ICU

1999 ◽  
Vol 27 (Supplement) ◽  
pp. 115A ◽  
Author(s):  
Karen K. Giuliano ◽  
Thomas L. Higgins ◽  
Eileen Pysznik ◽  
William McGee ◽  
Sue Perkins ◽  
...  
2019 ◽  
Author(s):  
Gurmukh Singh ◽  
Natasha M Savage ◽  
Brandy Gunsolus ◽  
Kellie A Foss

Abstract Objective Quick turnaround of laboratory test results is needed for medical and administrative reasons. Historically, laboratory tests have been requested as routine or STAT. With a few exceptions, a total turnaround time of 90 minutes has been the usually acceptable turnaround time for STAT tests. Methods We implemented front-end automation and autoverification and eliminated batch testing for routine tests. We instituted on-site intraoperative testing for selected analytes and employed point of care (POC) testing judiciously. The pneumatic tube system for specimen transport was expanded. Results The in-laboratory turnaround time was reduced to 45 minutes for more than 90% of tests that could reasonably be ordered STAT. With rare exceptions, the laboratory no longer differentiates between routine and STAT testing. Having a single queue for all tests has improved the efficiency of the laboratory. Conclusion It has been recognized in manufacturing that batch processing and having multiple queues for products are inefficient. The same principles were applied to laboratory testing, which resulted in improvement in operational efficiency and elimination of STAT tests. We propose that the target for in-laboratory turnaround time for STAT tests, if not all tests, be 45 minutes or less for more than 90% of specimens.


2020 ◽  
Author(s):  
Monisha Sharma ◽  
Edinah Mudimu ◽  
Kate Simeon ◽  
Anna Bershteyn ◽  
Jienchi Dorward ◽  
...  

2020 ◽  
Author(s):  
Monisha Sharma ◽  
Edinah Mudimu ◽  
Kate Simeon ◽  
Anna Bershteyn ◽  
Jienchi Dorward ◽  
...  

2021 ◽  
Vol 1 (7) ◽  
Author(s):  
Khai Tran ◽  
Jennifer Horton

Evidence on the clinical utility and cost-effectiveness of point-of-care devices could not be identified. Two evidence-based guidelines recommend a 2-bag regimen of N-acetylcysteine, consisting of both a loading dose and maintenance dose, administered by IV for patients with acute acetaminophen overdose.


Sign in / Sign up

Export Citation Format

Share Document